Nonmotor Fluctuations in Patients with Parkinson's Disease
Neurol 47:1180-1183, Hillen,M.E.&Sage,J.I., 1996
Ethical Use of Placebos and Provocative Testing in Diagnosing Nonepileptic Seizures
Neurol 47:866-870, Devinsky,O.&Fisher,R., 1996
Generalized Anxiety Disorder in Stroke Patients
Stroke 27:270-275, Astrom,M., 1996
Bent Spine Syndrome
JNNP 60:51-54, Serratrice,G.,et al, 1996
Cognitive Dysfunction as the Major Presenting Feature of Becker's Muscular Dystrophy
Neurol 46:461-465, North,K.N.,et al, 1996
Lewy Body Disease and Dementia
Arch Int Med 156:487-493, Kalra,S.,et al, 1996
Psychogenic Status Epilepticus Induced by a Provocative Technique
Neurol 46:546-547, Ney,G.C.,et al, 1996
Psychiatric Symptoms Do Not Correlate with Cognitive Decline, Motor Sympt or CAG Repeat Length in Huntington's
Arch Neurol 53:493-497, Zappacosta,B.,et al, 1996
Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996
Problems with Myofascial Pain Syndrome and Fibromyalgia Syndrome
Neurol 46:593-597, Bohr,T., 1996
A Woman with a Relapsing Psychosis Who Got Better with Prednisone
Lancet 347:1288, Cohen,L.,et al, 1996
Postictal Psychiatric Events During Prolonged Video-Electroencephalographic Monitoring Studies
Arch Neurol 53:258-263, Kanner,A.M.,et al, 1996
Risk Factors for Creutzfeldt-Jakob Disease:A Reanalysis of Case-Control Studies
Neurol 46:1287-1291, Wientjens,D.P.W.M.,et al, 1996
Primary Orthostatic Tremor
BMJ 310:143-144, Britton,T.C.&Thompson,P.D., 1995
Management of the Behavioral Manifestations of Dementia
Arch Int Med 155:250-260, Yeager,B.F.,et al, 1995
Drug Treatment of Parkinson's Disease
BMJ 310:575-579, Quinn,N., 1995
Low-Dose Clozapine in the Treatment of Levodopa-Induced Mental Disturbances in Parkinson's Disease
Neurol 45:432-434, Rabey,J.M.,et al, 1995
Non-Progressive Familial Idiopathic Intracranial Calcification:A Family Report
JNNP 59:432-434, Callender,J.S., 1995
Functional Dysphonia
BMJ 311:1039-1040, Wilson,J.A.,et al, 1995
New Phenotype of the Cerebral Autosomal Dominant Arteriopathy Mapped to Chromosome 19:Migraine as the Prominent Clinical Feature
JNNP 59:579-585, Verin,M.,et al, 1995
Eye Movement Abnormalities in Systemic Lupus Erythematosus
Arch Neurol 52:1145-1149, Keane,J.R., 1995
Neurotoxicity in Liver Transplant Recipients with Cyclosporine Immunosuppression
Neurol 45:1962-1964, Wijdicks,E.F.M.,et al, 1995
Psychogenic Movement Disorders:Frequency, Clinical Profile and Characteristics
JNNP 59:406-412, Factor,S.A.,et al, 1995
Psychiatric Illness in Patients with Syncope
Am J Med 99:505-512, Kapoor,W.N.,et al, 1995
Single Photon Emission Computed Tomography in Systemic Lupus Erythematosus with Psychiatric Symptoms
JNNP 58:307-311, Kodama,K.,et al, 1995
Silent Cerebral Infarctions in Patients with Late-Onset Mania
Stroke 26:946-949, Fujikawa,T.,et al, 1995
Psychiatric Classification of Nonconversion Nonepileptic Seizures
Arch Neurol 52:199-201, Alper,K.,et al, 1995
Dentatorubral-Pallidoluysian Atrophy:Clin Features Closely Related to Unstable Expansion of Trinucleotide (CAG) Repeat
Ann Neurol 37:769-775, Ikeuchi,T.,et al, 1995
Neuropsychiatric Lupus Erythematosus:A 10-Year Prospective Study on the Value of Diagnostic Tests
Am J med 99:153-163, West,S.G.,et al, 1995
Neuropsychiatric Aspects of HIV Infection
JNNP 58:399-402, Everall,I.P., 1995
Psychogenic Basilar Migraine:Report of Four Cases
Neurol 45:1291-1294, Villasenor,F.S.,et al, 1995
Acute Arcuate Fiber Demyelinating Encephalopathy Following Epstein-Barr Virus Infection
Ann Neurol 38:127-131, Paskavitz,J.F.,et al, 1995
Mitochondrial DNA and Disease
NEJM 333:638-644, Johns,D.R., 1995
Outcome in Conversion Disorder:A Follow Up Study
JNNP 58:750-752, Couprie,W.,et al, 1995
Psychogenic Parkinsonism
Arch Neurol 52:802-810, Lang,A.E.,et al, 1995
Psychosis in Advanced Parkinson's Disease:Treatment with Ondansetron, a 5-HT3 Receptor Antagonist
Neurol 45:1305-1308, Zoldan,J.,et al, 1995
Neurologic Abnormalities in Murderers
Neurol 45:1641-1647, Blake,P.Y.,et al, 1995
Psychosis as the Initial Manifestation of Adult-Onset Niemann-Pick Disease Type C
Neurol 45:1739-1743, Shulman,L.M.,et al, 1995
Patients with Multiple Sclerosis Presenting to Psychiatric Hospitals
J Clin Psychiatry 56:297-306, Pine,D.S.,et al, 1995
Post-Traumatic Movement Disorders:Central and Peripheral Mechanisms
Neurol 44:2006-2014, Jankovic,J., 1994
The Effects of 4-Aminopyridine in MS Pts:Randomized, Placebo-Controlled, Double-Blind, Concentration-Controlled, Crossover
Neurol 44:1054-1059, Bever,C.T.,et al, 1994
Dementia in 2 Histologically Confirmed Cases of MS:One Isolated Dementia & One Assoc with Psychiatric Symptoms
JNNP 57:353-359, Fontaine,B.,et al, 1994
Psychiatric Manifest of Systemic Lupus Erythematosus:Clin Features, Symptoms, & Signs of CNS Activity in 43 Pts
Medicine 73:224-232, Miguel,E.C.,et al, 1994
Seizure Disorder
Ciba Clin Symposia 46:4-34, Devinsky,O., 1994
Epilepsy
JNNP 57:264-277, Chadwick,D., 1994
Electroencephalography
JNNP 57:1308-1319, Binnie,C.D.&Prior,P.F., 1994
Somatisation in Neurlogic Practice
JNNP 57:1161-1164, Ron,M.A., 1994
Inborn Errors of Urea Synthesis
Ann Neurol 35:133-141, Batshaw,M.L., 1994
Clozapine:A 2-year Open Trial in Parkinson's Disease Patients with Psychosis
Neurol 44:544-546, Factor,S.A.,et al, 1994
Speculations on Antineuronal Antibody-Mediated Neuropsychiatric Disorders of Childhood
Pediatrics 93:323-325, Swedo,S.,et al, 1994